seawe
refer
divers
group
macroscop
multicellular
marin
alga
marin
alga
consum
sea
veget
diet
ingredi
medicin
sinc
ancient
time
countri
includ
korea
china
japan
one
earth
affluent
sourc
natur
antioxid
antimicrobi
seawe
also
contain
rich
varieti
vitamin
bl
c
e
riboflavin
niacin
pantothen
acid
folic
acid
well
miner
calcium
phosphoru
sodium
potassium
iodin
polysaccharid
laminarin
fucoidan
polyphenol
phlorotannin
carotenoid
pigment
fucoxanthin
astaxanthin
sterol
mycosporinelik
amino
acid
isol
seawe
past
among
marin
seawe
brown
alga
includ
ecklonia
speci
ishig
okamura
consider
evalu
speci
contain
phlorotannin
phlorotannin
phenyl
phenoxi
unit
differ
molecular
weight
present
marin
brown
alga
accord
linkag
phlorotannin
character
fuhalol
phlorethol
ether
linkag
fucol
phenyl
linkag
fucophloroethol
ether
phenyl
linkag
eckol
dibenzodioxin
linkag
ecklonia
abund
genu
kelp
brown
alga
associ
lessoniacea
famili
affluenc
eckoltyp
phlorotannin
eckol
precursor
compound
illustr
class
phlorotannin
contain
phloroglucinol
compon
link
multipl
fashion
figur
sever
marin
organ
known
produc
eckol
particularli
brown
tabl
red
alga
eckol
shown
exhibit
antioxid
antiinflammatori
hepatoprotect
neuroprotect
antiobes
antihypertens
antibacteri
antivir
activ
numer
health
benefit
particular
compound
prime
focu
research
eager
elucid
pharmacolog
potenti
tabl
figur
therefor
understand
biolog
activ
eckol
expand
effect
therapeut
approach
import
although
abund
inform
relat
compound
marin
alga
seawe
phlorotannin
seawe
access
littl
inform
avail
particular
type
phlorotannin
therefor
review
summar
biolog
character
pharmacolog
bioactiv
eckol
focus
recent
advanc
relat
particular
compound
lack
balanc
antioxid
freerad
bodi
lead
oxid
stress
free
radic
react
easili
molecul
human
bodi
lead
largechain
chemic
reaction
call
oxid
use
harm
human
cell
remov
ro
defens
system
mode
enzymat
nonenzymat
pathway
bodi
contain
free
reactiv
oxygen
speci
ro
beyond
defens
capac
ro
start
damag
fatti
tissu
nucleic
acid
protein
give
rise
vast
sum
diseas
time
includ
neurolog
disord
diabet
cancer
dermal
diseas
manganes
superoxid
dismutas
mnsod
antioxid
mitochondri
enzym
exhibit
cytoprotect
effect
oxid
stress
enzym
use
marker
evalu
antioxid
properti
phytochem
antioxid
eckol
recov
mnsod
express
activ
decreas
hydrogen
peroxid
pathway
phosphoryl
ampactiv
protein
kinaseforkhead
box
mnsod
express
induc
eckol
eckolstimul
mnsod
express
reduc
nm
specif
silenc
rna
sirna
ampk
addit
cytoprotect
activ
eckol
cell
death
reduc
diethyldithiocarbam
mnsod
inhibitor
thu
activ
induct
mnsod
eckol
protect
cell
oxid
stress
mitochondria
similarli
induct
heme
oxygenas
ho
mrna
protein
express
chines
hamster
lung
fibroblast
cell
concentr
timedepend
manner
due
eckol
result
high
activ
enhanc
phosphoryl
form
nuclear
transloc
antioxid
respons
element
bind
transcript
activ
observ
cell
upon
exposur
eckol
furthermor
mediat
eckolinduc
activ
promot
activ
induct
express
due
contribut
extracellular
relat
kinas
erk
phosphoinositid
kinas
b
assess
likeli
cytoprotect
activ
eckol
due
induct
cell
pretreat
inhibitor
zinc
protoporphyrin
transfect
sirna
nm
sirna
nm
markedli
reduc
cytoprotect
effect
eckol
cell
damag
suggest
involv
transcript
factor
eckolmedi
induct
addit
cytoprotect
effect
eckol
reduc
inhibitor
erk
kinas
nm
inhibitor
therefor
eckol
abil
attenu
oxid
stressinduc
cell
death
activ
via
erk
signal
eckol
isol
ecklonia
cava
cytoprotect
effect
oxid
stressinduc
cell
damag
cell
eckol
scaveng
dpph
radic
hydrogen
peroxid
hydroxi
radic
intracellular
ro
dosedepend
quench
effect
eckol
demonstr
radic
scaveng
effect
intracellular
ro
eckol
also
prevent
lipid
peroxid
thiobarbitur
acid
reactiv
substanc
tbar
assay
reduc
cell
death
cell
induc
eckol
treatment
decreas
nuclear
fragment
apoptot
dna
content
cell
induc
addit
eckol
exhibit
ro
scaveng
activ
cell
damag
via
serum
starvat
respect
eckol
also
influenc
activ
catalas
increas
dosedepend
manner
activ
phosphoryl
erk
furthermor
eckol
also
increas
transcript
activ
henc
eckol
capabl
exhibit
cellular
antioxid
activ
cytoprotect
antioxid
activ
five
compound
phloroglucinol
eckol
phlorofucofuroeckol
dieckol
eisenia
bicycli
examin
weight
gain
test
concentr
mixtur
eckol
phlorofucofuroeckol
effect
although
phloroglucinol
show
low
activ
effect
antioxid
activ
phlorotannin
seem
depend
degre
polymer
phloroglucinol
suggest
phlorotannin
lower
molecular
weight
eckol
phlorofucofuroeckol
potent
compar
higher
weight
dieckol
recent
studi
evalu
e
cava
extract
antioxid
potenti
airborn
particul
matter
pm
diamet
expos
cultur
keratinocyt
cultur
hacat
keratinocyt
expos
presenc
absenc
e
cava
extract
evalu
cell
viabil
cellular
lipid
peroxid
human
epiderm
keratinocyt
expos
use
examin
action
eckol
dieckol
cellular
lipid
peroxid
cytokin
express
decreas
cell
viabil
increas
lipid
peroxid
hacat
cell
expos
attenu
e
cava
extract
ethyl
acet
etoac
fraction
compar
eckol
dieckol
attenu
cellular
lipid
peroxid
effect
hacat
cell
human
epiderm
keratinocyt
inflammatori
cytokin
express
also
attenu
dieckol
eckol
human
epiderm
keratinocyt
stimul
diabet
mellitu
describ
group
diseas
affect
bodi
use
blood
sugar
glucos
chronic
diabet
condit
includ
type
diabet
type
diabet
bodi
make
insulin
common
insulinresist
state
bodi
fail
produc
enough
insulin
fail
respond
adequ
insulin
lead
high
glucos
concentr
blood
occurr
sever
hypoglycemia
relat
intens
insulin
therapi
lead
research
antihyperglycem
agent
focus
tradit
medicin
plant
could
provid
superior
treatment
compar
synthet
drug
methanol
extract
ecklonia
maxima
four
solventsolubl
fraction
three
phlorotannin
phloroglucinol
eckol
check
alphaglucosidas
inhibitori
activ
phloroglucinol
deriv
eckol
display
better
inhibit
posit
control
acarbos
show
eckol
potenti
compound
treatment
hyperglycemia
similarli
ecklonia
stoloniferaderiv
etoac
fraction
exhibit
inhibitori
effect
advanc
glycat
endproduct
age
format
rat
len
aldos
reductas
rlar
yield
phloroglucinol
dioxinodehydroeckol
eckol
phlorofucofuroeckola
dieckol
triphloretholb
e
stoloniferaderiv
phlorotannin
exhibit
rlar
inhibitori
activ
eckol
show
although
isol
phlorotannin
show
activ
age
inhibit
assay
result
contrast
anoth
studi
inhibitori
effect
isol
compound
glycat
eckol
dieckol
aminoguanidin
mm
accord
jung
et
al
reason
discrep
result
could
includ
differ
glycat
condit
glycat
step
detector
use
fluoresc
elisa
western
blot
analys
inhibit
compound
also
check
percent
inhibit
found
eckol
mm
accord
result
eckol
could
promis
treatment
agent
diabet
complic
may
possess
signific
inhibitori
effect
age
rlar
insight
antidiabet
potenti
eckol
provid
anoth
studi
methanol
extract
e
stolonifera
e
bicycli
fraction
six
isol
phlorotannin
test
protein
tyrosin
phosphatas
enzym
eckol
character
potent
inhibitor
moder
potent
inhibitor
henc
result
suggest
eckol
potenti
therapeut
agent
control
postprandi
blood
glucos
level
therebi
prevent
diabet
complic
liver
oper
make
protein
blood
clot
factor
produc
triglycerid
cholesterol
bile
synthes
glycogen
one
import
organ
abil
prevent
hepat
damag
vital
import
involv
detoxif
xenobiot
drug
acut
liver
injuri
model
mice
induc
carbon
tetrachlorid
use
investig
protect
effect
eckol
addit
possibl
mechan
rise
serum
level
alanin
transaminas
alt
ul
aspart
aminotransferas
ast
ul
suppress
pretreat
eckol
dose
mgkgday
day
amelior
morpholog
liver
injuri
termin
deoxynucleotidyl
transferasemedi
dutp
nick
end
label
tunel
analysi
reveal
decreas
number
apoptot
hepatocyt
eckoltr
group
compar
model
group
eckol
enhanc
express
suppress
express
cleav
reduc
malondialdehyd
format
enhanc
superoxid
dismutas
glutathion
peroxidas
activ
glutathion
content
elev
suppress
eckol
also
increas
level
antiinflammatori
cytokin
recruit
dendrit
cell
liver
tissu
mice
thu
inhibiton
apoptosi
oxid
inflamm
includ
immun
regul
multipl
mechan
relat
protect
effect
eckol
anoth
studi
hepatotox
primari
rat
hepatocyt
induc
doxorubicin
use
evalu
hepatoprotect
effect
edibl
varieti
korean
seawe
e
stolonifera
isol
phlorotannin
dioxinodehydroeckol
eckol
phlorofucofuroeckola
dieckol
triphlorethol
exhibit
hepatoprotect
valu
respect
import
molecular
weight
regard
hepatoprotect
effect
doxorubicininduc
cytotox
explain
fact
phloroglucinol
molecular
weight
low
molecular
weight
exhibit
effect
unlik
high
molecular
weight
phlorotannin
eckol
dieckol
conclus
eckol
suitabl
potenti
therapeut
treatment
hepatotox
compar
evalaut
phlorotannin
furthermor
activ
etoacsolubl
fraction
e
stolonifera
present
phlorotannin
phloroglucinol
dioxinodehydroeckol
eckol
phlorofucofuroeckola
dieckol
bioassayguid
fraction
determin
protect
cytotox
human
liverderiv
cell
induc
tacrin
except
dioxinodehydroeckol
phlorofucofuroeckola
exhibit
valu
respect
compound
includ
eckol
exhibit
activ
cell
cytotox
effect
tacrin
agedepend
disord
includ
neurodegen
diseas
prevail
peopl
live
longer
past
alzheim
diseas
ad
major
neurodegen
disord
character
increas
acetylcholinesteras
ach
level
around
plaqu
neurofibrillari
tangl
advers
intra
extracellular
effect
toxic
lewi
bodi
patholog
lead
anoth
preval
neurodegen
disord
known
parkinson
diseas
pd
due
sever
side
effect
synthet
neuroprotect
agent
grow
interest
nutraceut
herbal
altern
search
antiad
treatment
deriv
marin
plant
evalu
e
bicycli
phlorotannin
carri
eckol
isol
etoac
solubl
fraction
show
signific
activ
take
account
potent
activ
acetylcholinesteras
ach
butyryl
cholinesteras
bche
inhibitori
assay
ethanol
extract
korean
seawe
evalu
ethanol
extract
e
stolonifera
yield
nhexan
fraction
contain
sterol
fucosterol
etoac
fraction
contain
phlorotannin
phloroglucinol
dioxinodehydroeckol
eckol
phlorofucofuroeckola
dieckol
triphlorethola
eckol
exhibit
signific
ach
inhibit
valu
convers
eckol
exhibit
inhibitori
activ
bche
valu
differ
activ
explain
fact
ach
substratespecif
enzym
nerv
synaps
wherea
bche
nonspecif
enzym
plasma
tissu
show
involv
specif
bind
properti
enzym
substrat
similarli
studi
relat
e
maxima
crude
extract
solventsolubl
fraction
isol
phlorotannin
valu
solvent
solubl
fraction
rang
etoac
fraction
excel
inhibitori
activ
ach
compound
isol
etoac
fraction
identifi
phloroglucinol
two
deriv
eckol
eckol
exhibit
better
inhibitori
activ
ach
phloroglucinol
suggest
eckol
could
effect
ach
inhibitor
treatment
ad
sinc
inhibit
monoamin
oxidas
mao
import
manag
pd
eckol
dieckol
isol
methanol
extract
e
bicycli
investig
effect
degre
human
h
maoa
hmaob
inhibit
eckol
exhibit
valu
hmaoa
hmaob
respect
mix
noncompetit
inhibitori
mechan
reveal
biochem
molecular
dock
examin
henc
eckol
use
manag
pd
neurolog
disord
inhibit
mao
insomnia
current
widespread
sleep
disord
worldwid
lead
increas
use
natur
sleep
aid
contain
specif
compon
food
herbal
plant
thu
becom
popular
enhanc
sleep
qualiti
refrain
side
effect
compar
prescript
sedativehypnot
gammaaminobutyr
acid
gaba
bzd
receptor
wellrecogn
target
sedativehypnot
use
test
bind
activ
methanol
extract
seawe
among
seawe
activ
ethanol
extract
e
cava
significantli
increas
sleep
mice
induc
pentobarbit
among
four
separ
solvent
fraction
hypnot
activ
relat
content
total
phenol
total
phlorotannin
seawe
highest
activ
exhibit
etoac
fraction
constitut
phlorotannin
eckol
dioxinodehydroeckol
dieckol
triphlorethola
eckol
ki
dioxinodehydroeckol
ki
show
better
bind
receptor
triphlorethola
ki
dieckol
ki
hypnot
effect
ethanol
extract
etoac
fraction
inhibit
flumazenil
specif
receptor
antagonist
henc
posit
alloster
modul
receptor
phlorotannin
ec
includ
eckol
induc
sleep
involv
gprotein
coupl
receptor
human
pathophysiolog
pharmacolog
traceabl
emphas
design
implement
highthroughput
g
protein
coupl
receptor
function
assay
identifi
novel
drug
candid
dopamin
receptor
specif
therapeut
target
pd
schizophrenia
drug
abus
accord
stimulatori
inhibitori
properti
secondari
messeng
cyclic
adenosin
monophosph
dopamin
receptor
categor
receptor
concentr
eckol
confer
control
agonist
effect
human
dopamin
receptor
human
receptor
respect
eckol
agonist
respons
increas
give
valu
respect
howev
eckol
show
modul
effect
dopamin
serotonin
vasopressin
tachykinin
muscarin
receptor
context
molecular
dock
neg
bind
energi
kcalmol
exhibit
eckol
bound
activ
site
receptor
form
five
interact
similarli
eckol
bound
activ
site
caviti
neg
bind
energi
kcalmol
lower
dopamin
kcalmol
possibl
result
four
interact
even
though
eckol
form
salt
bridg
carboxyl
group
import
highaffin
ligand
bind
dopaminerg
receptor
form
interact
molecular
dynam
md
simul
show
interact
eckol
bind
pocket
chang
significantli
seven
water
molecul
involv
interact
eckol
md
simul
two
new
interact
residu
eckol
form
hbond
interact
distanc
import
activ
hand
display
hydrophob
interact
eckol
initi
conform
chang
protein
ligand
insid
bind
pocket
interact
also
bound
eticloprid
dopamin
contribut
stabil
ligand
insid
bind
pocket
conserv
serin
residu
helix
v
also
play
import
role
molecular
determin
agonistinduc
signal
dopamin
receptor
hydroxyl
moieti
eckol
present
interact
impli
eckol
dual
agonist
logpow
valu
excel
bind
plasma
protein
moder
human
intestin
absorpt
predict
silico
pharmacokinet
paramet
preadmet
also
vivo
barrier
penetr
calcul
show
moder
absorpt
central
nervou
system
although
ioniz
radiat
health
benefit
radiat
therapi
treatment
cancer
thyrotoxicosi
often
narrow
toxic
neighbor
normal
tissu
organ
natur
plant
extract
signific
potenti
adjunct
success
radiotherapi
lead
research
find
safer
less
expens
potent
radioprotector
ascertain
eckol
dose
mgkg
bodi
weight
given
h
h
exposur
gy
wholebodi
irradi
wbi
could
save
mice
radiat
gammaray
induc
damag
repres
significantli
diminish
death
rate
irradi
untreat
group
surviv
day
exposur
gy
wbi
mice
surviv
day
receiv
eckol
plu
irradi
endogen
colonyform
unit
cfu
assay
reveal
endogen
cfu
eckol
plu
irradi
group
irradi
control
group
respect
result
alter
nonirradi
group
treat
eckol
alon
reviv
hematopoiet
abil
splenic
progenitor
cell
due
eckol
indic
increas
number
cfu
decreas
percentag
tail
dna
eckol
treatment
irradiationdamag
lymphocyt
compar
content
tail
dna
expos
gy
wbi
shown
alkalin
comet
assay
thymidin
incorpor
splenocyt
increas
two
fold
day
eckoltr
irradi
mice
compar
untreat
one
furthermor
number
pan
cell
pan
b
elev
eckoltr
irradi
group
compar
irradi
untreat
control
group
increas
number
pan
b
cell
popul
compar
irradi
untreat
control
confirm
role
eckol
immunoprotect
elev
reviv
rate
specif
immun
cell
eckol
dieckol
also
examin
radioprotect
activ
intestin
stem
cell
pretreat
gammairradi
mice
day
irradi
gy
phloroglucinol
crypt
per
circumfer
eckol
crypt
per
circumfer
remark
increas
jejun
villi
height
n
per
group
compar
irradi
control
crypt
per
circumfer
number
surviv
crypt
also
increas
gammairradi
mice
day
irradi
gy
pretreat
phloroglucinol
eckol
compar
irradi
control
suggest
improv
surviv
jejun
crypt
irradi
mice
treat
compound
express
apoptot
nuclei
occur
mainli
lower
third
crypt
increas
irradi
shown
stain
situ
dna
end
label
isel
method
declin
number
apoptot
nuclei
observ
h
irradi
pretreat
phloroglucinol
eckol
compar
irradi
control
group
thu
improv
jejun
crypt
surviv
shield
apoptosi
induc
radiat
mous
jejun
crypt
observ
pretreat
phloroglucinol
eckol
support
radioprotect
potenti
eckol
e
cava
evalu
determin
cyto
histoprotect
abil
lymphocyt
intestin
damag
induc
whole
bodi
irradi
wbi
vivo
assess
whether
effect
eckol
inhibit
dna
damag
account
apoptot
chang
nuclear
morpholog
lymphocyt
assess
irradi
mice
peripher
blood
lymphocyt
easili
harm
ioniz
radiat
number
apoptot
nuclei
reduc
dramat
eckol
treat
group
comparison
irradi
control
group
versu
henc
viabil
peripher
blood
lymphocyt
protect
inhibit
apoptot
cell
death
induc
ioniz
radiat
vivo
frequenc
apoptot
fragment
crypt
cell
reduc
eckoltr
group
compar
untreat
group
h
wbi
treatment
reveal
abil
eckol
protect
intestin
crypt
cell
radiationinduc
apoptosi
increas
express
level
bax
commonli
seen
wbi
also
reduc
eckol
induct
express
level
involv
apoptosi
dna
repair
way
eckol
treatment
modul
immunohistochem
local
magnitud
apoptosisrel
protein
jejun
crypt
cell
therefor
eckol
administr
could
provid
great
benefit
cancer
patient
effect
prevent
apoptosi
peripher
blood
lymphocyt
intestin
crypt
cell
induc
radiat
furthermor
eckol
pretreat
scaveng
ro
cell
protect
dna
damag
decreas
adduct
dna
biomark
oxid
stress
eckol
also
decreas
lipid
peroxid
cell
apoptosi
induc
also
decreas
eckol
pretreat
cell
decreas
dna
fragment
increas
express
decreas
bax
express
irradi
cell
treat
eckol
inhibit
caspasedepend
pathway
via
mitochondria
major
pathway
suppress
eckol
decreas
irradiationinduc
apoptosi
addit
human
process
age
area
face
neck
dorsum
hand
forearm
get
affect
harm
effect
uv
light
photo
age
result
due
continu
uv
exposur
sun
damag
human
age
skin
lead
disorgan
collagen
fibril
aggreg
atyp
amorph
elastincontain
materi
photo
age
respons
undesir
ageassoci
transform
skin
includ
coars
wrinkl
sallow
color
telangiectasia
array
neoplasm
matrix
metalloproteinas
mmp
famili
express
certain
member
induc
uv
irradi
matrix
metalloproteinas
zinccontain
proteinas
degrad
collagen
extracellular
matrix
protein
compris
dermal
connect
tissu
proteolyt
event
human
system
includ
embryogenesi
wound
heal
inflamm
angiogenesi
cancer
involv
mmp
connect
tissu
damag
occur
photo
age
due
mmpmediat
collagen
destruct
major
factor
involv
deterior
dermal
collagen
process
age
evalu
seawe
extract
activ
compound
inhibit
express
led
seawe
e
stolonifera
e
bicycli
e
cava
exhibit
potent
inhibit
seawe
famili
also
show
protect
collagen
destruct
inhibit
express
eckol
dieckol
isol
e
stolonifera
diminish
express
induc
basal
express
reduc
report
gene
activ
human
dermal
fibroblast
henc
result
indic
reduct
express
due
compound
eckol
dieckol
excess
gener
ro
caus
oxid
stress
skin
due
uvb
radiat
ultim
damag
dna
lead
cancer
accord
studi
skin
cell
demonstr
damag
molecul
alter
structur
result
chang
cellular
function
also
due
uvb
radiat
insight
report
eckol
abil
protect
uvbinduc
oxid
cell
damag
human
skin
keratinocyt
hacat
eckol
decreas
uvbinduc
level
intracellular
ro
eventu
lower
damag
cellular
compon
caus
oxid
stress
cell
viabil
increas
uvbirradi
cell
treat
eckol
compar
uvb
irradi
cell
without
eckol
desir
develop
effect
chemoprevent
agent
uvbinduc
skin
cancer
human
led
assess
chemoprevent
efficaci
brown
alga
polyphenol
eckol
dieckol
phlorofucofuroeckol
phlorotannin
fucofuroeckol
variou
minor
homologu
photo
carcinogenesi
hairless
mous
skin
model
decreas
tumor
incid
seen
brown
algal
polyphenol
administ
diet
skin
moder
protect
skin
carcinogenesi
induc
uvb
radiat
mice
propag
tumor
decreas
p
p
treat
brown
polyphenol
diet
tumorstumorbear
mice
exhibit
inhibit
hand
topic
administr
mg
compound
reduc
tumor
multipl
p
p
respect
tumorstumorbear
mice
also
suppress
gene
express
cyclooxygenas
cox
decreas
level
skin
inhibit
amount
protein
reduc
rate
prolifer
cell
epidermi
summari
eckol
exert
protect
effect
skin
carcinogenesi
induc
uvb
radiat
also
anoth
studi
photoprotect
effect
phlorotannin
cell
damag
caus
uvb
radiat
demonstr
e
cavaisol
phlorotannin
phloroglucinol
eckol
dieckol
polyphenol
examin
protect
effect
uvbinduc
photooxid
stress
human
fibroblast
cell
eckol
exhibit
slightli
low
activ
uvb
radiationmedi
ro
ro
compar
dieckol
ro
level
ro
record
uvbirradi
cell
posit
control
eckol
show
cell
surviv
rate
concentr
respect
comet
assay
perform
evalu
whether
phlorotannin
protect
dna
damag
reveal
eckol
inhibitori
activ
concentr
respect
regul
blood
pressur
involv
angiotensinconvert
enzym
ace
potent
vasoconstrictor
whose
role
convert
angiotensin
angiotensin
ii
henc
ace
inhibit
play
physiolog
role
treatment
hypertens
natur
ace
inhibitor
altern
fewer
side
effect
compar
synthet
drug
major
interest
research
prevent
hypertens
among
ethanol
etoac
chloroform
hexan
diethyl
ether
extract
e
cava
strongest
ace
inhibitori
activ
demonstr
ethanol
extract
mgml
ethanol
extract
consist
phlorotannin
exhibit
potent
ace
inhibit
phloroglucinol
mm
triphlorethola
mm
eckol
mm
dieckol
mm
dioxinodehydroeckol
mm
eckol
show
lower
weakest
dioxinodehydroeckol
proteinbind
abil
phlorotannin
occur
revers
hydrogen
bond
irrevers
coval
condens
could
associ
ace
inhibit
similarli
signific
inhibit
concentr
exhibit
ethanol
extract
seawe
includ
e
stolonifera
e
cava
pelvetia
siliquosa
undaria
pinnatifida
grindelia
tenella
sinc
mark
ace
inhibitori
activ
exhibit
crude
extract
e
stolonifera
fraction
sever
solvent
order
determin
ace
inhibitori
properti
concentr
fucosterol
six
phlorotannin
phloroglucinol
dioxinodehydroeckol
eckol
phlorofucofuroeckola
dieckol
triphlorethola
success
isol
etoac
fraction
eckol
phlorofucofuroeckola
dieckol
display
valu
respect
show
import
closedr
moieti
observ
aceinhibit
anticoagul
commonli
describ
blood
thinner
inhibit
thrombin
factor
xa
serin
proteas
promot
stimul
activ
serin
proteas
inhibitor
serpinantithrombin
iii
difficulti
isol
heparin
primari
anticoagul
hemorrhag
side
effect
driven
research
isol
novel
anticoagul
natur
sourc
without
side
effect
eckol
isol
ecklonia
kurom
evalu
structur
requir
necessari
inhibit
macroglobulin
plasmin
inhibitor
main
plasmin
inhibitor
plasma
includ
inhibitor
eckol
exhibit
potent
specif
inhibitori
activ
action
synthesi
variou
methyl
deriv
eckol
studi
inhibitori
activ
antiplasmin
impli
simpl
skeleton
bear
function
group
could
becom
lead
compound
develop
new
class
thrombolyt
agent
similar
studi
eckol
act
antitrypsin
thrombin
inhibitor
howev
eckol
exhibit
weak
inhibit
antithrombin
iiiheparin
complex
exhibit
inhibit
plasmin
inhibitori
activ
eckol
reduc
whole
human
plasma
concentr
enhanc
urokinaseinduc
fibrinolysi
import
dioxan
skeleton
inhibit
plasmin
inhibitor
shown
sever
deriv
eckol
previous
state
skeleton
import
potent
antiinhibitor
activ
compar
hydroxyl
group
present
eckol
henc
result
suggest
simpl
skeleton
function
group
could
clinic
use
stimul
fibrinolysi
despit
boost
expans
antibacteri
agent
develop
multidrugresist
bacteria
creat
special
need
research
new
antibacteri
agent
need
grow
develop
power
natur
antimicrobi
agent
minim
side
effect
toxic
necess
public
health
studi
design
evalu
combin
activ
ampicillin
eckol
methicillinresist
staphylococcu
aureu
mrsa
salmonella
isol
reveal
antimicrobi
activ
eckol
toward
test
strain
minimum
inhibitori
concentr
mic
eckol
toward
aureu
salmonella
show
inhibit
concentrationdepend
manner
concentr
caus
reduct
cfu
time
show
least
decreas
bacteri
count
h
concentr
show
bacteriostat
activ
inhibit
expans
salmonella
period
h
fraction
inhibitori
concentr
index
rang
combin
eckol
ampicillin
show
high
inhibit
aureu
ampicillin
use
combin
eckol
compar
use
alon
etoacsolubl
extract
ferment
broth
e
bicycli
candida
utili
includ
eckol
dieckol
dioxinodehydroeckol
phlorofucofuroeckola
exhibit
strong
antimrsa
activ
mic
valu
rang
indic
potent
antimicrobi
inhibit
mrsa
foodborn
pathogen
bacteria
also
eckol
exhibit
mic
valu
propionibacterium
acn
kctc
p
acn
isol
p
acn
isol
staphylococcu
aureu
kctc
mic
valu
staphylococcu
epidermidi
kctc
viral
lifecycl
neuraminidas
na
play
critic
role
target
develop
drug
influenza
high
nainhibitori
activ
inhibit
etoac
layer
ethanol
extract
e
cava
led
bioactivityguid
fraction
isol
five
phlorotannin
phloroglucinol
eckol
phlorofucofuroeckol
dieckol
inhibitori
activ
kinet
behavior
phlorotannin
examin
na
use
variou
strain
influenza
viru
includ
ahong
eckol
demonstr
moder
valu
fail
show
signific
inhibit
viru
strain
compar
test
compound
phlorofucofuroeckol
dieckol
compound
increas
increas
hydroxyl
group
eckol
dieckol
indic
signific
definit
na
inhibitori
activ
due
number
hydroxyl
group
structur
phlorotannin
similarli
viral
hemorrhag
septicemia
viru
vhsv
fathead
minnow
fhm
cell
line
use
test
inhibit
efficaci
e
cava
extract
compound
low
concentr
extract
eckol
phlorofucofuroeckola
exhibit
potent
viru
inhibitori
activ
simultan
coexposur
vhsv
extract
eckol
phlorofucofuroeckola
fhm
inhibit
rate
increas
compar
pre
postexposur
strategi
valu
extract
eckol
phlorofucofuroeckola
respect
also
increas
exposur
time
led
high
activ
viru
fhm
cell
line
oral
administr
extract
oliv
flounder
challeng
vhsv
efficaci
vhsv
result
accord
vhsv
challeng
concentr
dose
extract
increas
proinflammatori
cytokin
express
activ
mx
indic
immunomodulatori
immunostimulatori
effect
extract
human
immunodefici
viru
hiv
retroviru
affect
cell
human
immun
system
infect
vital
organ
ultim
caus
immun
defici
lead
acquir
immun
defici
syndrom
aid
increas
failur
antiaid
treatment
due
strain
viru
becom
drugresist
research
drug
candid
higher
rate
inhibit
variou
strain
hiv
increas
major
focu
natur
deriv
compound
deriv
bioassaydirect
isol
e
cava
led
isol
eckol
bieckol
dieckol
phlorofucofuroeckola
inhibit
revers
transcriptas
rt
proteas
wherea
eckol
phlorofucofuroeckola
fail
show
activ
even
produc
rt
inhibitor
fraction
inhibit
mgml
given
import
sever
acut
respiratori
syndrom
coronaviru
proteinas
sarscov
viral
replic
biolog
assess
complet
phlorotannin
isol
e
cava
studi
e
cava
phlorotannin
shown
inhibit
competit
cellfre
system
phloroglucinol
triphlorethol
eckol
dioxinodehydroeckol
fucodiphloroethol
g
dieckol
phlorofucofuroeckola
isol
ethanol
extract
e
cava
except
phloroglucinol
phlorotannin
display
inhibit
hydrolysi
dosedepend
manner
valu
rang
eckol
dieckol
exhibit
potent
inhibitori
effect
sarscov
cellfre
cleavag
eckol
structur
essenti
crucial
good
inhibit
sarscov
high
food
intak
absenc
exercis
lead
obes
contribut
growth
metabol
syndrom
diabet
mellitu
atherosclerosi
osteoarthr
cardiovascular
diseas
nonalcohol
fatti
liver
diseas
order
investig
signific
e
cava
bodi
weight
fat
content
hyperglycemia
obes
mice
fed
extract
mgkg
e
cava
collect
jeju
jca
gijang
gca
week
highfat
diet
hfd
induct
high
perform
liquid
chromatographi
reveal
gca
mgg
jca
mgg
rich
eckol
gcahfd
mice
show
lower
bodi
weight
littl
weight
gain
decreas
reduc
alt
cholesterol
level
significantli
increas
mrna
level
peroxisom
proliferatoractiv
receptor
ppar
sterol
regulatori
elementbind
protein
srebp
adipogenicrel
transcript
factor
higher
fatti
acid
synthas
fa
compar
pbshfd
mice
jcahfd
mice
wherea
plasma
glucos
level
show
decreas
jcahfd
gcahfd
compar
pbshfd
due
relationship
obes
chronic
inflamm
express
inflammatori
cytokin
interleukin
il
macrophag
marker
elev
pbshfd
mice
compar
normal
chow
mice
gcahfd
mice
significantli
decreas
inflammatori
factor
compar
pbshfd
mice
increas
hepat
lipid
hfd
feed
caus
develop
nonalcohol
fatti
liver
condit
therefor
lipid
content
frozen
liver
section
assess
obviou
increas
lipid
droplet
accumul
pbshfd
mice
comparison
pbshfd
mice
decreas
lipid
droplet
triglycerid
content
gcahfd
jcafd
mice
also
mrna
express
acetylcoa
carboxylas
fa
gene
relat
lipid
metabol
significantli
decreas
gcahfd
mice
comparison
pbshfd
mice
obes
relat
adipogenesi
process
preadipocyt
differenti
adipocyt
due
high
energi
input
lack
exercis
adipogenesi
regul
multipl
process
includ
preadipocyt
prolifer
differenti
fatti
acid
oxid
synthesi
control
sever
factor
one
studi
inhibitori
effect
enzymetr
e
cava
extract
contain
three
distinct
phlorotannin
eckol
dieckol
phlorofucofuroeckola
separ
purifi
pectinas
cellulos
examin
adipogenesi
adipocyt
extract
appli
cell
hour
cell
viabil
increas
respect
glucos
util
decreas
mgdl
respect
triglycerid
accumul
also
decreas
mgdl
respect
treatment
extract
also
decreas
lipid
accumul
respect
adipocyt
includ
decreas
express
ccaatenhancerbind
protein
cebp
decreas
protein
level
adipocyt
fatti
acid
bind
protein
fa
adiponectin
also
observ
among
variou
potenti
target
treat
obes
human
pancreat
lipas
hold
great
potenti
pancreat
lipas
involv
absorpt
triglycerid
small
intestin
eventu
get
secret
pancrea
respons
hydrolysi
triglycerid
glycerol
fatti
acid
investig
methanol
extract
e
bicycli
reveal
signific
inhibit
pancreat
lipas
porcin
pancreat
lipas
assay
valu
mgml
lead
isol
eckol
fucofuroeckol
dioxinodehydroeckol
phlorofucofuroeckola
dieckol
sinc
eckol
lack
ether
linkag
posit
phlorotannin
skeleton
exhibit
much
weaker
activ
pancreat
lipas
fucofuroeckol
one
phloroglucinol
element
posit
also
molecular
weight
differ
compound
impact
pancreat
lipas
inhibitori
activ
exist
phloroglucinol
moieti
eckol
structur
posit
number
hydroxyl
group
eckol
fucofuroeckol
might
posit
influenc
inhibit
pancreat
lipas
probabl
uniqu
receptor
bind
abnorm
cell
growth
lead
invas
spread
throughout
bodi
defin
cancer
extern
factor
tobacco
alcohol
chemic
infecti
agent
radiat
intern
factor
hormon
immun
condit
inherit
mutat
mutat
occur
metabol
trigger
mutat
chromosom
dna
normal
cell
eventu
result
cancer
although
avail
antineoplast
drug
chemotherapi
detriment
aftermath
spark
search
natur
product
could
use
new
therapeut
agent
eckol
exhibit
wide
rang
therapeut
activ
also
test
cancer
treat
eckol
glioma
stemlik
cell
marker
selfrenewalrel
protein
chang
express
abil
form
sphere
anticanc
treatment
sensit
eckol
treatment
effect
reduc
sphere
format
cell
popul
conceal
express
glioma
stemlik
cell
marker
selfrenewalrel
protein
absenc
cell
deathth
fusion
eckol
glioma
stemlik
cell
diminish
tumor
format
anchorageindepend
growth
cell
soft
agar
xenograft
mice
eckol
decreas
resist
glioma
stemlik
cell
ioniz
radiat
temozolomid
addit
signal
pathway
block
due
eckol
treatment
glioma
stemlik
cell
henc
eckol
suppress
stem
malign
sensit
gliomastemlik
cell
anticanc
treatment
provid
novel
therapeut
strategi
specif
target
cell
anoth
studi
relat
anticanc
effect
four
phlorotannin
fucosterol
isol
character
e
maxima
compound
phloroglucinol
eckol
fucosterol
cytotox
effect
compound
test
cancer
cell
line
use
tetrazolium
bromid
mtt
reduct
assay
result
indic
eckol
highest
activ
select
cancer
cell
line
hela
cell
make
good
candid
promin
inhibitori
activ
metastasi
could
effect
reduc
cell
damag
chemic
immunolog
stimul
mast
cell
lead
discharg
intern
mediat
histamin
indic
cell
degranul
divers
sever
mediat
inflamm
eicosanoid
proteoglycan
proteas
includ
proinflammatori
chemotact
cytokin
il
lead
allerg
diseas
one
studi
vitro
assay
relat
hyaluronidas
inhibit
phlorotannin
evalu
e
bicycli
e
kurom
phlorotannin
exhibit
potent
inhibit
comparison
popular
inhibitor
catechin
sodium
cromoglyc
phloroglucinol
eckol
trimer
phlorofucofuroeckola
pentam
dieckol
bieckol
hexam
unknown
tetram
show
valu
respect
wherea
catechin
epigallocatechin
gallat
sodium
cromoglyc
valu
respect
accord
result
eckol
show
inhibitori
effect
hyaluronidas
activ
similarli
histamin
releas
assay
perform
human
basophil
leukemia
assess
antiallerg
activ
phloroglucinol
deriv
fucodiphloroethol
g
eckol
phlorofucofuroeckola
isol
e
cava
inhibitori
potenti
releas
histamin
evalu
abil
inhibit
immunoglobulin
e
ige
antiig
antibodi
stimul
degranul
cell
fucodiphloroethol
g
eckol
phlorofucofuroeckola
display
rel
histamin
releas
respect
highest
concentr
cell
calcium
ionophor
mediat
inhibitori
effect
phlorotannin
histamin
releas
percentag
cell
treat
fucodiphloroethol
g
eckol
phlorofucofuroeckola
degranul
percentag
cell
respect
eckol
fewer
hydroxyl
function
group
two
compound
show
less
inhibit
histamin
releas
cell
line
particularli
compar
fucodiphloroethol
g
compris
hydroxyl
function
group
molecular
structur
amount
phenol
group
could
import
factor
fucodiphloroethol
g
phlorofucofuroeckola
show
strong
activ
eckol
also
potent
inhibit
bind
activ
ige
receptor
treat
highest
concentr
fucodiphloroethol
g
phlorofucofuroeckola
wherea
eckol
display
less
inhibiton
flow
cytometr
analysi
thu
eckol
e
cava
show
moder
antiallerg
activ
compar
compound
due
structur
differ
amid
compound
term
number
hydroxyl
group
linkag
among
phenol
unit
lead
differ
inhibitori
activ
accord
sugiura
et
al
suppress
releas
cell
phlorotannin
occur
accord
molecular
size
number
phenol
group
although
eckol
exhibit
significantli
lower
activ
posit
control
epigallocatechin
gallat
isol
phlorotannin
phlorofucofuroeckolb
phlorofucofuroeckola
show
inhibitori
activ
similar
greater
epigallocatechin
gallat
model
rat
fed
diet
includ
eisenia
arborea
allergi
symptom
improv
possibl
due
suppress
effect
isol
phlorotannin
enzym
releas
histamin
occurr
infect
endotoxin
exposur
cell
injuri
bodi
result
complex
defens
feedback
call
inflamm
basic
lead
reviv
normal
cell
structur
function
mark
elev
permeabl
fluid
solut
due
disturb
vascular
barrier
integr
central
pathophysiolog
mechan
sever
vascular
inflammatori
diseas
sepsi
atherosclerosi
therefor
chang
permeabl
endotheli
barrier
contribut
occurr
anaphylaxi
sepsi
acut
lung
injuri
eckol
deriv
evalu
barrier
protect
effect
proinflammatori
respons
human
umbil
vein
endotheli
cell
huvec
mice
accord
result
eckol
dieckol
isol
e
bicycli
show
inhibit
barrier
disrupt
mediat
lp
transendotheli
migrat
leukocyt
human
endotheli
cell
concentr
addit
eckol
inhibit
acet
acidinduc
hyperperm
leukocyt
migrat
induc
vivo
interestingli
accord
result
obtain
hydrogen
donat
hydroxyl
group
present
dieckol
regul
protect
abil
better
eckol
similarli
signal
pathway
involv
protect
action
eckol
dieckol
includ
phloroglucinol
proinflammatori
respons
huvec
highmobl
group
box
proteintr
mice
investig
phlorotannin
inhibit
lp
ngml
induc
releas
express
tolllik
receptor
addit
also
inhibit
barrier
disrupt
medid
express
cell
adhes
molecul
cam
eselectin
transendotheli
migrat
leukocyt
human
endotheli
cell
addit
suppress
hyperperm
induc
aceticacid
leukocyt
migrat
induc
carboxymethylcellulos
vivo
explain
import
hydroxyl
group
protect
action
chang
methyl
group
hydroxyl
posit
dieckol
diminish
vascular
barrier
protect
effect
arachidon
acid
aa
deriv
lipidmedi
secretori
phospholipas
esteras
cleav
glycerophospholipid
posit
ultim
liber
fatti
acid
lysophospholipid
present
synovi
fluid
articular
cartilag
blood
patient
suffer
rheumat
diseas
anoth
lipid
mediat
deriv
arachidon
acid
involv
inflamm
biosynthes
pathway
depend
cox
lipoxygenas
lox
enzym
inhibitor
enzym
could
treat
inflammatori
diseas
atherosclerosi
cancer
five
phlorotannin
ie
phloroglucinol
eckol
dieckol
phlorofucofuroeckola
bieckol
purifi
e
bicycli
evalu
potenti
inhibit
bee
venom
porcin
pancrea
secretori
phospholipas
soybean
lipoxygenas
case
bee
venom
phlorotannin
eckol
phlorofucofuroeckola
dieckol
resveratrol
epigallocatechin
gallat
demonstr
valu
respect
eckol
phlorofucofuroeckola
dieckol
bieckol
show
high
activ
comparison
posit
control
resveratrol
epigallocatechin
gallat
porcin
pancrea
eckol
phlorofucofuroeckola
dieckol
bieckol
demostr
valu
respect
eckol
show
less
inhibit
soybean
lipoxygenas
lox
potent
inhibitor
soybean
lox
show
inhibit
phlorotannin
neglig
inhibitori
effect
eckol
exhibit
inhibit
acn
vulgari
p
acn
bacteria
stimul
keratinocyt
activ
il
inflammatori
mediat
includ
nitric
oxid
secret
increas
mmp
degrad
collagen
dermi
infect
acn
predict
form
degradeddisintegr
collagen
tissu
p
acnesinduc
inflammatori
respons
hacat
cell
due
eckol
slightli
decreas
mrna
level
also
p
acn
activ
pathway
relat
inflammatori
mediat
ino
also
phosphoryl
activ
subunit
eckol
gradual
decreas
activ
concentrationdepend
manner
wherea
treatment
p
acn
acceler
phosphoryl
akt
inhibit
eckol
hacat
cell
anoth
studi
arachidon
acid
aa
tpa
oxazolon
oxa
use
three
sensit
induc
ear
edema
institut
cancer
research
icr
mice
eckol
bieckol
phlorofucofuroeckola
phlorofucofuroeckolb
suppress
ear
edema
dose
mg
phlorotannin
behav
strongli
toward
ear
edema
treat
aa
oxa
rather
tpa
sensit
inhibit
phlorotannin
similar
manner
epigallocatechin
gallat
typic
inhibitor
follow
research
e
arborea
purifi
six
phlorotannin
phlorofucofuroeckola
phlorofucofuroeckolb
eckol
administ
oral
mice
initi
evalu
inhibitori
effect
compound
swell
ear
determin
suppress
abil
phlorotannin
cultur
mast
cell
model
use
cell
evalu
releas
histamin
leukotrien
prostaglandin
includ
mrna
express
activ
eckol
suppress
degranul
concentr
rbl
cell
compar
epigallocatechin
gallat
result
phlorotannin
show
potent
inhibit
phlorofucofuroeckola
highest
activ
increas
level
lipid
fat
cholesterol
triglycerid
blood
lead
sever
acquir
genet
disord
refer
hyperlipidemia
cardiovascular
heart
diseas
major
complic
hyperlipidemia
prevent
appropri
use
medic
healthi
lifestyl
search
antihyperlipidem
agent
effect
eckol
dieckol
isol
ethanol
extract
e
stolonifera
investig
lipid
level
serum
hyperlipidem
rat
highcholesterol
diet
poloxam
use
induc
hyperlipidemia
rat
rat
fed
highcholesterol
diet
show
elev
level
tc
mgdl
tg
mgdl
ldlc
mgdl
serum
well
increas
atherogen
index
ai
eckol
dose
mgkg
bodi
weight
day
day
reduc
serum
tc
mgdl
tg
mgdl
ldlc
mgdl
addit
hdlc
level
hyperlipidem
control
rat
induc
poloxam
mgdl
eckoltr
rat
increas
mgdl
oxid
ldl
one
caus
agent
atherosclerosi
inhibitori
effect
e
stolonifera
fraction
phlorotannin
isol
conjug
dien
format
methanol
extract
investig
vitro
human
ldl
oxid
thiobarbitur
acid
reactiv
substanc
tbar
assay
reveal
methanol
extract
concentrationdepend
inhibitori
activ
ldl
oxid
induc
valu
etoac
fraction
e
stolonifera
show
high
inhibit
valu
among
isol
phlorotannin
phloroglucinol
dioxinodehydroeckol
eckol
phlorofucofuroeckol
dieckol
phlorofucofuroeckola
dieckol
found
potent
ldl
oxid
inhibitor
eckol
show
moder
inhibit
exhibit
valu
product
conjug
dien
indic
start
ldl
oxid
lag
time
use
measur
ldl
oxid
resist
eckol
extend
lag
time
min
min
min
probucol
posit
control
increas
lag
time
min
min
min
thu
eckol
effect
probucol
inhibit
conjug
dien
format
tyrosinas
coppercontain
enzym
catalyz
product
melanin
pigment
ltyrosin
oxid
blacken
peel
slice
potato
expos
air
improv
hyperpigment
relat
disord
melasma
age
spot
relat
decreas
tyrosinas
activ
seventeen
test
seawe
e
stolonifera
show
high
tyrosinas
inhibitori
activ
phlorotannin
isol
activ
etoacsolubl
fraction
e
stolonifera
phloroglucinol
dioxinodehydroeckol
eckol
phlorofucofuroeckola
dieckol
show
valu
respect
mushroom
tyrosinas
phloroglucinol
eckol
display
higher
inhibit
arbutin
dieckol
show
three
time
higher
inhibit
kojic
acid
noncompetit
inhibit
mushroom
tyrosinas
exhibit
eckol
phlorofucofuroeckola
dieckol
ki
valu
respect
similar
studi
tyrosinas
inhibit
eckol
deriv
e
cava
evalu
melanogenesi
bind
capac
use
molecular
dock
simul
impact
eckol
melanin
synthesi
evalu
melanoma
cell
induc
stimul
hormon
eckol
suppress
melanin
synthesi
tyrosinas
activ
inhibit
tyrosinas
express
cell
compar
eckol
arbutin
posit
control
present
weaker
inhibit
tyrosinas
activ
field
eckol
shown
promis
result
antihair
loss
antihear
loss
antiosteoporosi
treatment
hair
loss
also
known
alopecia
bald
describ
loss
hair
head
bodi
sever
vari
small
section
whole
bodi
one
studi
evalu
effect
e
cava
promot
hair
growth
treatment
e
cava
enzymat
extract
compound
isol
result
prolifer
immort
vibrissa
dermal
papilla
cell
dpc
dpc
treat
compound
isol
e
cava
enzymat
extract
includ
eckol
dieckol
phloroglucinol
triphlorethola
concentr
day
result
prolifer
dpc
respect
sinc
mitot
effect
fibroblast
via
katp
channel
open
lead
promot
hair
growth
e
cava
enzymat
extract
eckol
dieckol
phloroglucinol
triphlorethola
test
abil
hair
growth
eckol
increas
prolifer
fibroblast
extent
compar
control
group
eckol
dieckol
also
inhibit
activ
dosedepend
manner
import
prevent
hair
loss
anoth
studi
protect
effect
eckol
link
antihear
loss
activ
prevent
temporari
threshold
shift
tt
implic
noiseinduc
hear
loss
nihl
receiv
lot
consider
among
teenag
recent
year
temporari
threshold
shift
type
nihl
acceler
agerel
hear
loss
even
transient
one
primari
caus
tt
ro
protect
activ
polyphenol
extract
e
cava
ppee
evalu
result
decreas
ro
level
notabl
compound
ppee
typic
polyphenol
found
e
cava
includ
dieckol
phlorofucofuroeckola
eckol
contribut
antioxid
potenti
intraperiton
administr
ppee
mgkg
salin
mice
exposur
nois
significantli
decreas
auditori
brainstem
respons
threshold
shift
provid
signific
degre
protect
relat
distort
product
otoacoust
emiss
level
thu
eckol
contain
ppee
may
good
potenti
break
viciou
cycl
tt
bonerel
disord
lead
imbal
bone
mass
osteoporosi
treat
format
bone
tissu
osteoblast
differenti
togeth
suppress
possibl
caus
bone
volum
loss
close
connect
onset
osteoblastogenesi
obes
dm
major
concern
treatment
age
patient
sinc
natur
product
trend
attenu
osteoporosi
e
cava
bioactiv
constitu
test
effect
adipogen
differenti
fibroblast
osteoblast
differenti
preosteoblast
triphlorethola
eckol
dieckol
exhibit
antiadipogen
activ
reduc
lipid
aggreg
suppress
express
adipogen
differenti
marker
also
enhanc
osteoblast
differenti
shown
rais
alkalin
phosphatas
action
increas
level
indic
relat
osteoblastogenesi
also
affect
intracellular
calcif
dieckol
activ
compound
follow
triphlorethola
eckol
osteoporot
condit
outlin
review
eckol
evalu
copious
broad
spectrum
activ
establish
potenti
therapeut
agent
accord
variou
experiment
result
eckol
possess
wide
array
therapeut
properti
variou
studi
eckol
establish
antioxid
howev
evid
use
cellbas
experi
limit
henc
result
cellbas
experi
could
act
futur
refer
vivo
experi
doubtlessli
highlight
antioxid
potenti
eckol
also
shown
promis
result
diabet
suppress
sinc
diabet
incur
suppress
time
scientist
alway
verg
find
new
compound
pathway
cure
diseas
eckol
evalu
role
exist
signal
pathway
diabet
would
interest
see
effect
eckol
newli
discov
pathway
evalu
one
furthermor
eckol
contraind
use
hepatoprotect
cellular
level
show
hepatoprotect
activ
vivo
model
possibl
reason
discrep
could
differ
toxicityinduc
agent
employ
studi
eckol
ineffect
tacrineinduc
toxic
human
liver
cell
line
exhibit
protect
effect
toxic
mice
model
henc
eckol
fail
protect
liver
cell
tacrineinduc
toxic
need
detail
research
know
exact
mechan
involv
neuroprotect
receptor
dopamin
receptor
hold
good
futur
eckol
due
potent
activ
receptor
high
activ
eckol
ach
enzym
inhibit
bche
inhibit
explain
select
natur
includ
moder
hmaob
inhibit
although
enzym
inhibit
effect
display
neuroprotect
natur
cellbas
vivo
experi
imper
show
actual
therpeut
sever
diseas
requir
radiat
therapi
includ
cancer
radioprotect
utmost
import
although
vivo
experi
show
eckol
radioprotector
still
mani
complic
consider
use
human
clinic
trial
correct
dose
eckol
requir
radiat
utmost
import
part
henc
studi
could
refer
eckol
could
develop
pharmaceut
product
eckol
show
moder
protect
role
skin
cell
uv
radiat
scaveng
ro
reduc
intracellular
oxid
damag
induc
uvb
radiat
vivo
experi
also
support
eckol
uv
protector
skin
carcinogenesi
henc
eckol
could
potent
uv
protector
pharmaceut
cosmeceut
regard
anticoagul
properti
skeleton
eckol
seem
one
major
factor
involv
anticoagul
effect
requir
investig
although
eckol
show
potent
anticoagul
effect
via
thrombin
activ
inhibit
activ
reduc
whole
plasma
probabl
due
bind
affect
efficaci
henc
search
altern
increas
bioavail
could
good
futur
research
similarli
antithrombot
activ
eckol
also
support
possibl
develop
eckol
anticoagul
antihypertens
effect
eckol
attribut
aceinhibit
closedr
crucial
inhibit
still
vivo
studi
requisit
establish
eckol
pharmaceut
product
furthermor
follow
success
character
eckol
anticanc
agent
via
vitro
cellbas
studi
eckol
could
test
vivo
establish
full
potenti
lifethreaten
diseas
sever
contraind
eckol
less
activ
inact
allerg
symptom
report
compound
fucodiphloroethol
g
phlorofucofuroeckol
dieckol
eckol
show
potent
activ
basic
skeleton
eckol
could
crucial
role
antiallerg
activ
worth
confirm
antiallerg
properti
eckol
vivo
term
antivir
antibacteri
activ
eckol
show
emin
result
product
proinflammatori
cytokin
respons
antivir
activ
extract
contain
eckol
contraindicatori
point
even
though
increas
proinflammatori
cytokin
may
lead
inflamm
subsequ
basal
express
level
cytokin
signific
increas
earli
stage
oral
administr
extract
indic
immunomodulatori
activ
extract
henc
extract
activ
antiinflammatori
respons
suppress
proinflammatori
cytokin
control
extent
inflammatori
condit
eckol
exhibit
potent
antiinflammatori
activ
point
note
introduct
dimer
isom
eckol
surpass
activ
eckol
appear
potent
even
though
potent
geometri
aromat
ring
main
configur
eckol
skeleton
alway
critic
suppress
properti
cellbas
experi
relat
tyrosinas
inhibit
eckol
could
also
benefici
futur
refer
experi
live
subject
potent
antihyperlipidem
activ
eckol
compar
probucol
suppress
high
lipid
level
serum
hyperlipidem
rat
could
evid
develop
pharmaceut
agent
hyperlipidemia
antihair
loss
antihear
loss
activ
eckol
show
still
hold
potenti
sever
unidentifi
field
one
state
review
henc
continu
evalu
eckol
futur
import
increas
spectrum
activ
numer
effort
establish
natur
biomark
treatment
variou
ailment
improv
understand
function
activ
consid
divers
natur
biomark
eckol
definit
push
requir
decod
kind
compound
proper
use
eckol
exhibit
sever
biolog
activ
extraordinari
particularli
involv
eckol
antioxid
antidiabet
radioprotect
hepatoprotect
antiinflammatori
agent
name
use
eckol
antihair
loss
antihear
loss
refresh
new
discoveri
increas
scope
eckol
neuroprotect
agent
evalu
g
protein
coupl
dopamin
receptor
also
novel
explor
treatment
major
neurodegen
disord
like
alzheim
parkinson
diseas
thu
introduc
eckol
variou
new
receptor
relat
differ
diseas
usual
one
could
great
interest
sinc
eckol
exhibit
activ
lifethreaten
diseas
like
cancer
research
particular
field
also
hold
great
potenti
eckol
establish
anticanc
agent
major
reason
broad
spectrum
activ
relat
eckol
possibl
due
structur
even
potent
phlorotannin
famili
basic
backbon
eckol
develop
eckol
singl
pharmaceut
product
could
benefici
field
medicin
henc
natur
productderiv
compound
hold
multitud
opportun
discoveri
novel
therapeut
agent
shift
focu
synthet
develop
agent
natur
agent
could
step
stone
advanc
treatment
variou
infirm
conclus
kind
natur
deriv
drug
immens
potenti
advanc
pharmaceut
medic
field
lead
definit
chang
view
